These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 27887202

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical utility of serological markers in inflammatory bowel disease.
    Mokrowiecka A, Daniel P, Słomka M, Majak P, Malecka-Panas E.
    Hepatogastroenterology; 2009; 56(89):162-6. PubMed ID: 19453050
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Serological markers of inflammatory bowel disease in children from the Western region of Saudi Arabia.
    Saadah OI, Al-Mughales JA.
    Arab J Gastroenterol; 2013 Jun; 14(2):78-82. PubMed ID: 23820506
    [Abstract] [Full Text] [Related]

  • 5. The prevalence and diagnostic value of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease in mainland China.
    Zhou F, Xia B, Wang F, Shrestha UK, Chen M, Wang H, Shi X, Chen Z, Li J.
    Clin Chim Acta; 2010 Oct 09; 411(19-20):1461-5. PubMed ID: 20570669
    [Abstract] [Full Text] [Related]

  • 6. Analysis of serum antibodies in patients suspected of having inflammatory bowel disease.
    Jaskowski TD, Litwin CM, Hill HR.
    Clin Vaccine Immunol; 2006 Jun 09; 13(6):655-60. PubMed ID: 16760323
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies.
    Schoepfer AM, Trummler M, Seeholzer P, Seibold-Schmid B, Seibold F.
    Inflamm Bowel Dis; 2008 Jan 09; 14(1):32-9. PubMed ID: 17924558
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic role and clinical association of ASCA and ANCA in Brazilian patients with inflammatory bowel disease.
    Nisihara RM, de Carvalho WB, Utiyama SR, Amarante H, Baptista ML.
    Dig Dis Sci; 2010 Aug 09; 55(8):2309-15. PubMed ID: 19826949
    [Abstract] [Full Text] [Related]

  • 10. Serological markers predict inflammatory bowel disease years before the diagnosis.
    van Schaik FD, Oldenburg B, Hart AR, Siersema PD, Lindgren S, Grip O, Teucher B, Kaaks R, Bergmann MM, Boeing H, Carbonnel F, Jantchou P, Boutron-Ruault MC, Tjønneland A, Olsen A, Crowe FL, Peeters PH, van Oijen MG, Bueno-de-Mesquita HB.
    Gut; 2013 May 09; 62(5):683-8. PubMed ID: 22842615
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Diagnostic value of antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibody in Iranian patients with inflammatory bowel disease.
    Bahari A, Aarabi M, Aarabi M, Hedayati M, Jarollahi A, Firouzi F, Aghazadeh R, Zali MR, Hashemi M.
    Acta Gastroenterol Belg; 2009 May 09; 72(3):301-5. PubMed ID: 19902862
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Predictive value of serologic markers in a population-based Norwegian cohort with inflammatory bowel disease.
    Solberg IC, Lygren I, Cvancarova M, Jahnsen J, Stray N, Sauar J, Schreiber S, Moum B, Vatn MH, IBSEN Study Group.
    Inflamm Bowel Dis; 2009 Mar 09; 15(3):406-14. PubMed ID: 19009607
    [Abstract] [Full Text] [Related]

  • 16. Serological antibodies and surgery in a population-based inception cohort of Crohn's disease patients - the IBSEN study.
    Kristensen VA, Cvancarova M, Høivik ML, Moum B, Vatn MH.
    Scand J Gastroenterol; 2020 Apr 09; 55(4):436-441. PubMed ID: 32252542
    [Abstract] [Full Text] [Related]

  • 17. The diagnostic accuracy of serologic markers in children with IBD: the West Virginia experience.
    Elitsur Y, Lawrence Z, Tolaymat N.
    J Clin Gastroenterol; 2005 Sep 09; 39(8):670-3. PubMed ID: 16082274
    [Abstract] [Full Text] [Related]

  • 18. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role.
    Quinton JF, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, Charrier G, Targan SR, Colombel JF, Poulain D.
    Gut; 1998 Jun 09; 42(6):788-91. PubMed ID: 9691915
    [Abstract] [Full Text] [Related]

  • 19. The value of serum antibodies in differentiating inflammatory bowel disease, predicting disease activity and disease course in the newly diagnosed patient.
    Smids C, Horjus Talabur Horje CS, Groenen MJM, van Koolwijk EHM, Wahab PJ, van Lochem EG.
    Scand J Gastroenterol; 2017 Oct 09; 52(10):1104-1112. PubMed ID: 28661185
    [Abstract] [Full Text] [Related]

  • 20. pANCA and ASCA in the diagnosis of different subtypes of inflammatory bowel disease.
    Mokrowiecka A, Gasiorowska A, Malecka-Panas E.
    Hepatogastroenterology; 2007 Oct 09; 54(77):1443-8. PubMed ID: 17708273
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.